(+)-PENTAZOCINE-DEA SCHEDULE IV ITEM
(+)-PENTAZOCINE-DEA SCHEDULE IV ITEM structure
|
Common Name | (+)-PENTAZOCINE-DEA SCHEDULE IV ITEM | ||
|---|---|---|---|---|
| CAS Number | 7361-76-4 | Molecular Weight | 285.424 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 403.5±45.0 °C at 760 mmHg | |
| Molecular Formula | C19H27NO | Melting Point | N/A | |
| MSDS | USA | Flash Point | 180.8±27.4 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | cis-(+)-pentazocine |
|---|---|
| Synonym | More Synonyms |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 403.5±45.0 °C at 760 mmHg |
| Molecular Formula | C19H27NO |
| Molecular Weight | 285.424 |
| Flash Point | 180.8±27.4 °C |
| Exact Mass | 285.209259 |
| LogP | 4.53 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.554 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H312-H332 |
| Precautionary Statements | P280 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| RIDADR | NONH for all modes of transport |
|
Allosteric modulation of sigma-1 receptors elicits anti-seizure activities.
Br. J. Pharmacol. 172 , 4052-65, (2015) Application of orthosteric sigma-1 receptor agonists as anti-seizure drugs has been hindered by questionable efficacy and potential adverse effects. Here, we have investigated the anti-seizure effects... |
|
|
Involvement of hypothalamic neuropeptide Y in pentazocine induced suppression of food intake in rats.
Neuropeptides 48(3) , 133-41, (2014) The potent orexigenic peptide neuropeptide Y (NPY) has been considered as a possible endogenous ligand for a subpopulation of sigma receptors (SigR). However, their mutual interaction with reference t... |
|
|
Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.
J. Med. Chem. 57(24) , 10404-23, (2014) The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. T... |
| PENTAZOCINE, (+)- |
| 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2S,6S,11S)- |
| (1S,9S,13S)-1,13-Dimethyl-10-(3-methyl-2-buten-1-yl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol |
| (2S,6S,11S)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol |
| A2G9VU2P2J |
| PENTAZOCINE |
| cis-(+)-pentazocine |
| (+)-pentazocine |
| EINECS 206-634-6 |
| α-(+)-Pentazocine |